Tamper seals and packaging integrity: authenticity checking from the buyer's side

A tamper seal does not prove what is inside the vial. It proves one narrow but useful thing: that this particular closure has not been opened since the seal was applied — by whoever applied it. ISO 21976:2018 sets out requirements and guidance for applying, using and checking tamper verification features on medicinal product packaging, and its logic is exactly that: the feature must be destroyed or irreversibly altered by opening, so that interference is recognisable without tools and without training ^[1]. About identity, purity or provenance it says nothing at all. Authenticity checking from the buyer's side begins there; it does not end there.

The second reality is legal, and commercial copy usually leaves it out: for research material there is no sealing obligation whatsoever. The European regime that mandates an anti-tampering device applies only to human medicinal products ^[2]. A lyophilised synthetic substance supplied as a laboratory reagent sits outside that scope, so any seal you find on it is a voluntary supplier practice: chosen by the supplier, applied by the supplier, audited by nobody. That does not make it worthless. It makes it one element to be weighed alongside others, rather than proof that stands on its own.

What a tamper seal actually attests

ISO 21976 was built on the European technical specification CEN/TS 16679:2014 and describes the categories that dominate the market: adhesive tapes and labels, shrink sleeves, breakable caps, and glued carton flaps ^[1]. Whichever is chosen, the performance criterion is the same: opening must leave a mark that cannot be restored. A cap that unscrews and screws back on without a trace is not a tamper seal, however tight it feels.

There are three questions no seal answers, and they are worth stating outright. First, who applied it: an intact seal attests continuity from the point of sealing onwards, not that this point was a factory. Second, what was sealed: if the contents were swapped before crimping, the seal is perfect and the vial is wrong. Third, how hard it is to reproduce: holograms, VOID tapes and shrink bands are sold openly by the roll, and a hand crimper for aluminium caps costs less than a modest order. A seal is a statement about the container's history after sealing, not about its contents before.

What the law demands of medicines and does not demand of reagents

Directive 2011/62/EU introduced "safety features" into European pharmaceutical law as the answer to falsified medicines entering the legal supply chain ^[2]. Delegated Regulation (EU) 2016/161 then specified two of them: a unique identifier, printed as a two-dimensional barcode and verifiable against a national repository, and an anti-tampering device — a seal in the strict sense. The rules have applied since 9 February 2019 ^[3]. Greece used the deferral the Directive allowed for member states that already operated a national verification system — in its case the authenticity strip — and moved to the European system six years later, on 9 February 2025, at which point the strip ceased to be the means of verifying a pack ^[2].

None of that applies to research-use material. There is no legally mandated anti-tampering device, no serialised code, no repository in which to check whether a code has already been decommissioned, and the Greek medicines agency, EOF, keeps no register for materials outside the pharmaceutical field. The only European legislation that touches the packaging of such substances is chemical rather than pharmaceutical: the CLP Regulation requires, for certain hazard classes and only where the substance is supplied to the general public, a child-resistant fastening conforming to EN ISO 8317 and a tactile warning of danger conforming to EN ISO 11683 ^[4]. Conformity of those closures is verified by testing in accredited laboratories — in Greece accreditation is granted by ESYD — but their purpose is protecting children, not indicating interference. On a shelf the two are easy to confuse; in an assessment they must not be.

The seal types you meet, and what each one withstands

The standard that judges how serious such a solution is happens to be ISO 22383:2020, which gives performance criteria and an evaluation methodology for authentication solutions for material goods, starting from a counterfeiting risk assessment ^[5]. Two of its points are directly useful to a buyer. First, it separates overt elements, checkable with the naked eye, from covert and forensic ones, which need a tool or a laboratory. Second, it makes resistance to copying and to reuse a selection criterion. An off-the-shelf hologram fails both: it is overt and it is available to anyone. A bespoke hologram design with serial numbering is a different object — and a rare one in this market.

What you inspect on receipt, and in what order

The inspection happens before anything is opened, with the parcel still on the bench. Order matters: once a seal is broken, you can no longer prove to anyone what condition it reached you in.

• Outer packaging: tears re-closed with a different tape, doubled tape layers, corners with adhesive residue or lifted paper fibre — cardboard remembers the first opening.
• VOID tape: the pattern appears once only; re-application leaves either a visible indication or bubbles and lifted edges.
• Heat-shrink band: even application right around the circumference, with no thickening, creasing or patches where the material melted unevenly — a second shrink is rarely clean.
• Aluminium crimp: the skirt should be continuous and flat right around. An uneven or slightly lifted skirt, radial scratches, and a deformed plastic flip-off button are indications of re-sealing ^[10].
• Rubber stopper: a visible needle hole, a depression, or shed rubber particles mean the vial has already been pierced.
• Lyophilised contents: the form of the cake, its position, and any residue on the walls are recorded photographically; they prove no identity, but they document condition at receipt.
• Batch number matched across vial label, certificate of analysis and dispatch note; a mismatch of even one character is a non-conformance, not a typing slip.
• Label: substance name, date and research-use statement printed — not handwritten, not stuck over a previous label.

Batch matching is the point at which a seal acquires evidential weight, and it is worth explaining why. Without it, the certificate of analysis describes some material — just not demonstrably yours, however carefully you read what each field on that certificate is actually claiming. With it, the intact seal bridges the gap between the document and the object: the same container, closed from sealing until it reached your hand. The chain breaks at whichever link is missing, and it is usually the same link — the dispatch note that carries no batch number at all.

Why visual inspection is not enough for falsified peptides

Here we owe the reader more candour than the average commercial page offers. The literature on falsified pharmaceutical products keeps arriving at the same conclusion: packaging inspection is a screening step, not an identification step, because the appearance of a pack is far easier to reproduce than its contents, and confirming identity requires chemical analysis ^[9] — analysis that has boundaries of its own, since a matching mass confirms a molecular weight rather than a sequence. The scale of the problem is not hypothetical: the World Health Organization, reviewing a hundred studies covering more than 48,000 samples from 88 countries, estimated a 10.5% failure rate among medical products in low- and middle-income countries ^[7]. That estimate concerns medicines in particular markets and does not transfer intact to research reagents inside the European Union — but it shows how systematic the phenomenon is where it has been measured. The closer parallel for this market is the small number of studies that have tested what grey-market peptide vials actually contain.

At the European border, the joint report of the EU Intellectual Property Office and the Commission's Directorate-General for Taxation and Customs Union recorded roughly 112 million counterfeit articles detained at the border and in the internal market during 2024, with an estimated value above 3.8 billion euro ^[8]. That figure is not about peptides specifically and should not be presented as though it were; it is about infrastructure. Anyone who can print retail packaging at that scale can print a vial label.

Laboratory integrity tests do exist, but they are not the recipient's tools. ASTM F1929, for instance, detects seal leaks in porous medical packaging by dye penetration, and defines its detection limit as a channel equivalent to one formed by a 50 µm wire in the edge seal ^[6]. It is qualitative, destructive and designed for sterile barrier systems — not for a crimped glass vial, and not for a goods-in desk. The practical conclusion is unwelcome and should be said plainly: a re-seal performed with a proper crimper and a clean cap cannot be told apart by eye. Visual inspection catches careless interference, and only that.

The receiving record that survives scrutiny

1. Photograph the parcel closed, with the carrier label legible, before any tape is cut.
2. Photograph every vial with the seal intact, from two angles, with the batch number readable.
3. Record date and time of receipt, the recipient's name, and the condition of the outer packaging on a receiving sheet with a unique number.
4. Match line by line: label batch, certificate of analysis batch, dispatch note batch.
5. Quarantine anything that does not agree — separate space, clear marking, no use — and open a non-conformance record before contacting the supplier.
6. Keep the packaging materials of a disputed delivery: the seal, the band and the carton are the evidence, and they are the first thing thrown away.

Such a record is not bureaucracy; it is the only thing that converts an impression into a claim. Without a photograph of the intact seal taken before opening, every complaint to a supplier, a carrier or an authority ends in the same deadlocked exchange of accounts. With a photograph, a timestamp and a batch number, the conversation changes register — and, more importantly, becomes checkable by a third party.

Where the evidence is genuinely weak

Three things deserve acknowledgement without hedging. First, there is no standard, certification scheme or authority policing seals on research reagents; talk of "factory sealing" is a supplier claim, of the same class as a declaration of conformity — it may be perfectly true, but it is not independent testimony. Second, the overt authentication elements that dominate here have, by ISO 22383's own criteria, low resistance to copying, because they are procured as standard consumables ^[5]. Third, and most importantly: packaging integrity and content identity are independent questions. A perfectly intact vial may hold a different substance; a vial with a creased band may be entirely correct and merely mishandled in transit.

The opposite error is just as common: concluding that because a seal proves no identity, it carries no value. It does, and a specific one. It is the only indication covering the interval between sealing and receipt — the interval in which substitution in transit, the return of opened stock to a shelf, and opening by a third party all occur. No analytical report covers that interval, because every report concerns a sample drawn before it. The two checks are not in competition; they cover different segments of one line, and the line is only as strong as its weakest segment.